West Pharma price target raised by UBS; rating kept at Buy
UBS maintained West Pharma at Buy and raised its price target to $415.00 per share from $340.00, according to TradingView News and Benzinga’s ratings action summary.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.